JANX Insider Transactions — Page 3
309 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 201–300; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Lichter Jay | TenPercentOwner | 2024-09-10 | Sale | 35,047.0 | $46.66 |
| Avalon Ventures XI, L.P. | TenPercentOwner | 2024-09-10 | Sale | 35,047.0 | $46.66 |
| Avalon BioVentures SPV I, L.P. | TenPercentOwner | 2024-09-10 | Sale | 35,047.0 | $46.66 |
| Avalon BioVentures I, LP | TenPercentOwner | 2024-09-10 | Sale | 35,047.0 | $46.66 |
| Lichter Jay | TenPercentOwner | 2024-09-10 | Sale | 6,649.0 | $46.66 |
| Avalon Ventures XI, L.P. | TenPercentOwner | 2024-09-10 | Sale | 6,649.0 | $46.66 |
| Avalon BioVentures SPV I, L.P. | TenPercentOwner | 2024-09-10 | Sale | 6,649.0 | $46.66 |
| Avalon BioVentures I, LP | TenPercentOwner | 2024-09-10 | Sale | 6,649.0 | $46.66 |
| Lichter Jay | TenPercentOwner | 2024-09-10 | Sale | 34,326.0 | $46.66 |
| Avalon Ventures XI, L.P. | TenPercentOwner | 2024-09-10 | Sale | 34,326.0 | $46.66 |
| Avalon BioVentures SPV I, L.P. | TenPercentOwner | 2024-09-10 | Sale | 34,326.0 | $46.66 |
| Avalon BioVentures I, LP | TenPercentOwner | 2024-09-10 | Sale | 34,326.0 | $46.66 |
| Lichter Jay | TenPercentOwner | 2024-09-10 | Sale | 11,557.0 | $46.13 |
| Avalon Ventures XI, L.P. | TenPercentOwner | 2024-09-10 | Sale | 11,557.0 | $46.13 |
| Avalon BioVentures SPV I, L.P. | TenPercentOwner | 2024-09-10 | Sale | 11,557.0 | $46.13 |
| Avalon BioVentures I, LP | TenPercentOwner | 2024-09-10 | Sale | 11,557.0 | $46.13 |
| Lichter Jay | TenPercentOwner | 2024-09-10 | Sale | 2,193.0 | $46.13 |
| Avalon Ventures XI, L.P. | TenPercentOwner | 2024-09-10 | Sale | 2,193.0 | $46.13 |
| Avalon BioVentures SPV I, L.P. | TenPercentOwner | 2024-09-10 | Sale | 2,193.0 | $46.13 |
| Avalon BioVentures I, LP | TenPercentOwner | 2024-09-10 | Sale | 2,193.0 | $46.13 |
| Lichter Jay | TenPercentOwner | 2024-09-10 | Sale | 11,319.0 | $46.13 |
| Avalon Ventures XI, L.P. | TenPercentOwner | 2024-09-10 | Sale | 11,319.0 | $46.13 |
| Avalon BioVentures SPV I, L.P. | TenPercentOwner | 2024-09-10 | Sale | 11,319.0 | $46.13 |
| Avalon BioVentures I, LP | TenPercentOwner | 2024-09-10 | Sale | 11,319.0 | $46.13 |
| Lichter Jay | TenPercentOwner | 2024-09-09 | Sale | 2,182.0 | $42.33 |
| Avalon Ventures XI, L.P. | TenPercentOwner | 2024-09-09 | Sale | 2,182.0 | $42.33 |
| Avalon BioVentures SPV I, L.P. | TenPercentOwner | 2024-09-09 | Sale | 2,182.0 | $42.33 |
| Avalon BioVentures I, LP | TenPercentOwner | 2024-09-09 | Sale | 2,182.0 | $42.33 |
| Lichter Jay | TenPercentOwner | 2024-09-06 | Sale | 110,644.0 | $42.0 |
| Avalon Ventures XI, L.P. | TenPercentOwner | 2024-09-06 | Sale | 110,644.0 | $42.0 |
| Avalon BioVentures SPV I, L.P. | TenPercentOwner | 2024-09-06 | Sale | 110,644.0 | $42.0 |
| Avalon BioVentures I, LP | TenPercentOwner | 2024-09-06 | Sale | 110,644.0 | $42.0 |
| Lichter Jay | TenPercentOwner | 2024-09-06 | Sale | 20,991.0 | $42.0 |
| Avalon Ventures XI, L.P. | TenPercentOwner | 2024-09-06 | Sale | 20,991.0 | $42.0 |
| Avalon BioVentures SPV I, L.P. | TenPercentOwner | 2024-09-06 | Sale | 20,991.0 | $42.0 |
| Avalon BioVentures I, LP | TenPercentOwner | 2024-09-06 | Sale | 20,991.0 | $42.0 |
| Lichter Jay | TenPercentOwner | 2024-09-06 | Sale | 108,365.0 | $42.0 |
| Avalon Ventures XI, L.P. | TenPercentOwner | 2024-09-06 | Sale | 108,365.0 | $42.0 |
| Avalon BioVentures SPV I, L.P. | TenPercentOwner | 2024-09-06 | Sale | 108,365.0 | $42.0 |
| Avalon BioVentures I, LP | TenPercentOwner | 2024-09-06 | Sale | 108,365.0 | $42.0 |
| Lichter Jay | Director,TenPercentOwner | 2024-06-03 | Sale | 691,525.0 | $54.75 |
| Lichter Jay | Director,TenPercentOwner | 2024-06-03 | Sale | 131,196.0 | $54.75 |
| Lichter Jay | Director,TenPercentOwner | 2024-06-03 | Sale | 677,279.0 | $54.75 |
| Reardon Tighe | Acting Chief Financial Officer | 2024-06-03 | Sale | 691,525.0 | $54.75 |
| Reardon Tighe | Acting Chief Financial Officer | 2024-06-03 | Sale | 131,196.0 | $54.75 |
| Avalon Ventures XI, L.P. | TenPercentOwner | 2024-06-03 | Sale | 691,525.0 | $54.75 |
| Avalon BioVentures SPV I, L.P. | TenPercentOwner | 2024-06-03 | Sale | 691,525.0 | $54.75 |
| Avalon BioVentures I, LP | TenPercentOwner | 2024-06-03 | Sale | 691,525.0 | $54.75 |
| Avalon Ventures XI, L.P. | TenPercentOwner | 2024-06-03 | Sale | 131,196.0 | $54.75 |
| Avalon BioVentures SPV I, L.P. | TenPercentOwner | 2024-06-03 | Sale | 131,196.0 | $54.75 |
| Avalon BioVentures I, LP | TenPercentOwner | 2024-06-03 | Sale | 131,196.0 | $54.75 |
| Avalon Ventures XI, L.P. | TenPercentOwner | 2024-06-03 | Sale | 677,279.0 | $54.75 |
| Avalon BioVentures SPV I, L.P. | TenPercentOwner | 2024-06-03 | Sale | 677,279.0 | $54.75 |
| Avalon BioVentures I, LP | TenPercentOwner | 2024-06-03 | Sale | 677,279.0 | $54.75 |
| Reardon Tighe | Acting Chief Financial Officer | 2023-11-13 | Purchase | 849,854.0 | $5.87 |
| Lichter Jay | Director,TenPercentOwner | 2023-11-13 | Purchase | 849,854.0 | $5.87 |
| Avalon Ventures XI, L.P. | TenPercentOwner | 2023-11-13 | Purchase | 849,854.0 | $5.87 |
| Avalon BioVentures SPV I, L.P. | TenPercentOwner | 2023-11-13 | Purchase | 849,854.0 | $5.87 |
| Avalon BioVentures I, LP | TenPercentOwner | 2023-11-13 | Purchase | 849,854.0 | $5.87 |
| RA Capital Healthcare Fund LP | Director,TenPercentOwner | 2023-07-19 | Purchase | 495,008.0 | $12.46 |
| RA CAPITAL MANAGEMENT, L.P. | Director,TenPercentOwner | 2023-07-19 | Purchase | 495,008.0 | $12.46 |
| Kolchinsky Peter | Director,TenPercentOwner | 2023-07-19 | Purchase | 495,008.0 | $12.46 |
| Shah Rajeev M. | Director,TenPercentOwner | 2023-07-19 | Purchase | 495,008.0 | $12.46 |
| RA Capital Nexus Fund II, L.P. | Director | 2023-07-19 | Purchase | 495,008.0 | $12.46 |
| ORBIMED ADVISORS LLC | Director | 2021-12-29 | Sale | 3,700.0 | $20.3 |
| OrbiMed Genesis GP LLC | Director | 2021-12-29 | Sale | 3,700.0 | $20.3 |
| OrbiMed Capital GP VIII LLC | Director | 2021-12-29 | Sale | 3,700.0 | $20.3 |
| ORBIMED ADVISORS LLC | Director | 2021-12-29 | Sale | 36,700.0 | $20.3 |
| OrbiMed Genesis GP LLC | Director | 2021-12-29 | Sale | 36,700.0 | $20.3 |
| OrbiMed Capital GP VIII LLC | Director | 2021-12-29 | Sale | 36,700.0 | $20.3 |
| Thompson Peter A. | Director | 2021-12-29 | Sale | 3,700.0 | $20.3 |
| Thompson Peter A. | Director | 2021-12-29 | Sale | 36,700.0 | $20.3 |
| ORBIMED ADVISORS LLC | Director | 2021-12-21 | Sale | 11,100.0 | $19.0 |
| OrbiMed Genesis GP LLC | Director | 2021-12-21 | Sale | 11,100.0 | $19.0 |
| OrbiMed Capital GP VIII LLC | Director | 2021-12-21 | Sale | 11,100.0 | $19.0 |
| ORBIMED ADVISORS LLC | Director | 2021-12-21 | Sale | 108,300.0 | $19.0 |
| OrbiMed Genesis GP LLC | Director | 2021-12-21 | Sale | 108,300.0 | $19.0 |
| OrbiMed Capital GP VIII LLC | Director | 2021-12-21 | Sale | 108,300.0 | $19.0 |
| Thompson Peter A. | Director | 2021-12-21 | Sale | 11,100.0 | $19.0 |
| Thompson Peter A. | Director | 2021-12-21 | Sale | 108,300.0 | $19.0 |
| Thompson Peter A. | Director | 2021-12-16 | Sale | 36,500.0 | $19.07 |
| Thompson Peter A. | Director | 2021-12-16 | Sale | 356,800.0 | $19.07 |
| ORBIMED ADVISORS LLC | Director | 2021-12-16 | Sale | 36,500.0 | $19.07 |
| OrbiMed Capital GP VII LLC | Director | 2021-12-16 | Sale | 36,500.0 | $19.07 |
| OrbiMed Genesis GP LLC | Director | 2021-12-16 | Sale | 36,500.0 | $19.07 |
| ORBIMED ADVISORS LLC | Director | 2021-12-16 | Sale | 356,800.0 | $19.07 |
| OrbiMed Capital GP VII LLC | Director | 2021-12-16 | Sale | 356,800.0 | $19.07 |
| OrbiMed Genesis GP LLC | Director | 2021-12-16 | Sale | 356,800.0 | $19.07 |
| Bregua Corp | TenPercentOwner | 2021-06-15 | Purchase | 58,823.0 | $17.0 |
| Thompson Peter A. | Director | 2021-06-15 | Purchase | 117,650.0 | $17.0 |
| Thompson Peter A. | Director | 2021-06-15 | Purchase | 588,203.0 | $17.0 |
| ORBIMED ADVISORS LLC | Director | 2021-06-15 | Purchase | 117,650.0 | $17.0 |
| OrbiMed Genesis GP LLC | Director | 2021-06-15 | Purchase | 117,650.0 | $17.0 |
| OrbiMed Capital GP VIII LLC | Director | 2021-06-15 | Purchase | 117,650.0 | $17.0 |
| ORBIMED ADVISORS LLC | Director | 2021-06-15 | Purchase | 588,203.0 | $17.0 |
| OrbiMed Genesis GP LLC | Director | 2021-06-15 | Purchase | 588,203.0 | $17.0 |
| OrbiMed Capital GP VIII LLC | Director | 2021-06-15 | Purchase | 588,203.0 | $17.0 |
| Reardon Tighe | Acting Chief Financial Officer | 2021-06-15 | Purchase | 629,411.0 | $17.0 |
| Lichter Jay | Director,TenPercentOwner | 2021-06-15 | Purchase | 629,411.0 | $17.0 |
| Avalon Ventures XI, L.P. | TenPercentOwner | 2021-06-15 | Purchase | 629,411.0 | $17.0 |